Ella Zomer Selected Research

imazodan

11/2020

The Health and Productivity Burden of Migraines in Australia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ella Zomer Research Topics

Disease

19	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 05/2012
5	Hypertension (High Blood Pressure) 07/2022 - 05/2012
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 11/2020
4	Heart Failure 01/2021 - 01/2019
3	Stroke (Strokes) 07/2022 - 11/2018
3	Type 2 Diabetes Mellitus (MODY) 07/2022 - 01/2021
3	Neoplasms (Cancer) 01/2022 - 01/2018
3	Myocardial Infarction 07/2020 - 01/2019
2	Coronary Disease (Coronary Heart Disease) 01/2023 - 07/2022
2	Disease Progression 01/2022 - 11/2020
2	Dementia (Dementias) 12/2018 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2013 - 05/2012
1	Chest Pain (Chest Pains) 01/2023
1	Heart Diseases (Heart Disease) 07/2022
1	Dyslipidemias (Dyslipidemia) 07/2022
1	Obesity 01/2022
1	Acute Coronary Syndrome 10/2021
1	Kidney Diseases (Kidney Disease) 04/2021
1	Migraine Disorders (Migraine) 11/2020
1	Knee Osteoarthritis 02/2019
1	Frailty 01/2019
1	Carotid Artery Diseases 01/2019
1	Pain (Aches) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Peripheral Arterial Disease 01/2019
1	Vascular Diseases (Vascular Disease) 11/2018
1	Hip Osteoarthritis (Coxarthrosis) 01/2018
1	Developmental Dysplasia of the Hip 01/2018
1	Premature Birth (Birth, Premature) 01/2018
1	Osteophyte 01/2018
1	Mental Disorders (Mental Disorder) 02/2016
1	Diabetes Mellitus 04/2013
1	Liver Diseases (Liver Disease) 01/2008

Drug/Important Bio-Agent (IBA)

13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 11/2012
5	LipidsIBA 01/2023 - 10/2019
3	oxidized low density lipoproteinIBA 01/2023 - 07/2022
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2020
3	Guanosine Diphosphate (GDP)IBA 01/2022 - 01/2021
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 04/2013
2	Insulin (Novolin)FDA Link 01/2023 - 11/2020
2	LDL CholesterolIBA 07/2022 - 11/2020
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 09/2020
2	RivaroxabanIBA 01/2019 - 11/2018
2	CholesterolIBA 02/2016 - 05/2012
2	Antihypertensive Agents (Antihypertensives)IBA 04/2013 - 05/2012
1	TroponinIBA 01/2023
1	CarnosineIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	eicosapentaenoic acid ethyl esterIBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Enalapril FDA LinkGeneric 01/2021
1	dapagliflozinIBA 01/2021
1	imazodanIBA 11/2020
1	Adenosine Triphosphate (ATP)IBA 11/2020
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 11/2020
1	citrate (pro-3S)-lyaseIBA 11/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2020
1	Neprilysin (Neutral Endopeptidase)IBA 09/2020
1	Angiotensin Receptor AntagonistsIBA 09/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2020
1	ALN-PCSIBA 01/2020
1	C-Reactive ProteinIBA 01/2019
1	AnticoagulantsIBA 01/2019
1	canakinumab FDA Link 01/2019
1	Vitamin D FDA LinkGeneric 06/2015
1	AcidsIBA 04/2013
1	urotensin IIIBA 01/2008

Therapy/Procedure

13	Therapeutics 01/2023 - 05/2012
3	Secondary Prevention 10/2022 - 01/2019
1	Percutaneous Coronary Intervention 10/2021
1	CARE protocol 08/2021
1	Injections 11/2020
1	Patient Readmission 07/2020
1	Replacement Arthroplasty 02/2019
1	Complementary Therapies (Alternative Medicine) 01/2019
1	Length of Stay 11/2018
1	Denervation 11/2018
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 04/2013